tiprankstipranks
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market
CPHRF
Cipher Pharmaceuticals
RESEARCH TOOLSreports

Cipher Pharmaceuticals (CPHRF) Ratios

21 Followers

Cipher Pharmaceuticals Ratios

CPHRF's free cash flow for Q2 2026 was $0.66. For the 2026 fiscal year, CPHRF's free cash flow was decreased by $ and operating cash flow was $0.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.59 1.12 1.94 9.19 4.07
Quick Ratio
 1.11 0.79 1.64 8.62 3.84
Cash Ratio
 0.47 0.30 0.90 7.58 3.08
Solvency Ratio
 1.84 1.16 0.26 3.92 2.85
Operating Cash Flow Ratio
 1.39 1.21 0.98 3.05 1.13
Short-Term Operating Cash Flow Coverage
 111.97 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 11.33M$ -2.21M$ -21.68M$ 42.76M$ 28.46M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.04 0.25 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 0.04 0.40 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 0.04 0.28 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.04 0.28 0.00 0.00
Financial Leverage Ratio
 1.14 1.24 1.59 1.07 1.15
Debt Service Coverage Ratio
 89.57 29.05 0.00 0.00 0.00
Interest Coverage Ratio
 118.77 14.17 0.00 0.00 0.00
Debt to Market Cap
 <0.01 0.02 0.16 0.00 0.00
Interest Debt Per Share
 0.02 0.26 1.64 0.01 0.02
Net Debt to EBITDA
 -0.36 -0.08 1.92 -3.42 -2.36
Profitability Margins
Gross Profit Margin
70.55%65.79%72.24%80.77%80.69%
EBIT Margin
38.75%32.73%23.52%48.68%53.45%
EBITDA Margin
49.53%46.94%35.56%54.48%58.23%
Operating Profit Margin
38.75%32.73%23.52%54.48%58.23%
Pretax Profit Margin
35.22%34.02%8.86%59.92%55.52%
Net Profit Margin
58.81%54.17%34.60%96.32%128.83%
Continuous Operations Profit Margin
58.81%54.17%34.60%96.32%128.83%
Net Income Per EBT
166.98%159.23%390.69%160.74%232.04%
EBT Per EBIT
90.87%103.94%37.65%109.99%95.35%
Return on Assets (ROA)
18.51%17.80%7.10%23.69%36.10%
Return on Equity (ROE)
22.74%22.07%11.28%25.31%41.57%
Return on Capital Employed (ROCE)
13.93%12.80%5.50%14.27%18.69%
Return on Invested Capital (ROIC)
13.90%12.78%5.49%14.26%18.66%
Return on Tangible Assets
41.44%41.55%17.41%29.73%48.15%
Earnings Yield
10.99%9.95%4.69%19.15%37.41%
Efficiency Ratios
Receivables Turnover
 4.07 4.59 2.41 4.16 3.04
Payables Turnover
 2.16 2.75 1.58 0.88 0.97
Inventory Turnover
 1.57 2.15 1.60 1.36 1.86
Fixed Asset Turnover
 119.55 90.38 49.06 52.64 42.98
Asset Turnover
 0.31 0.33 0.21 0.25 0.28
Working Capital Turnover Ratio
 5.94 4.75 1.08 0.59 0.90
Cash Conversion Cycle
 152.79 116.85 148.44 -60.88 -58.67
Days of Sales Outstanding
 89.76 79.53 151.63 87.76 120.08
Days of Inventory Outstanding
 231.98 169.90 228.30 267.49 196.76
Days of Payables Outstanding
 168.95 132.58 231.50 416.13 375.51
Operating Cycle
 321.74 249.43 379.93 355.25 316.85
Cash Flow Ratios
Operating Cash Flow Per Share
 1.07 1.19 0.79 0.63 0.42
Free Cash Flow Per Share
 1.06 1.19 0.79 0.63 0.42
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 220.05 1.06K 444.23 111.10 130.56
Capital Expenditure Coverage Ratio
 220.05 1.06K 444.23 111.10 130.56
Operating Cash Flow Coverage Ratio
 73.83 5.50 0.48 45.32 24.71
Operating Cash Flow to Sales Ratio
 0.55 0.59 0.59 0.76 0.51
Free Cash Flow Yield
10.21%10.81%7.93%15.01%14.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.11 10.06 21.31 5.22 2.67
Price-to-Sales (P/S) Ratio
 5.35 5.44 7.37 5.03 3.44
Price-to-Book (P/B) Ratio
 1.93 2.22 2.40 1.32 1.11
Price-to-Free Cash Flow (P/FCF) Ratio
 9.79 9.25 12.61 6.66 6.78
Price-to-Operating Cash Flow Ratio
 9.75 9.24 12.59 6.65 6.73
Price-to-Earnings Growth (PEG) Ratio
 0.07 0.08 -0.52 -0.21 0.01
Price-to-Fair Value
 1.93 2.22 2.40 1.32 1.11
Enterprise Value Multiple
 10.44 11.52 22.65 5.81 3.55
Enterprise Value
 254.97M 277.49M 268.74M 66.94M 42.79M
EV to EBITDA
 10.44 11.52 22.65 5.81 3.55
EV to Sales
 5.17 5.41 8.05 3.16 2.07
EV to Free Cash Flow
 9.47 9.18 13.78 4.19 4.08
EV to Operating Cash Flow
 9.43 9.17 13.75 4.18 4.05
Tangible Book Value Per Share
 1.98 1.44 0.25 2.47 1.82
Shareholders’ Equity Per Share
 5.40 4.94 4.14 3.16 2.55
Tax and Other Ratios
Effective Tax Rate
 -0.67 -0.59 -2.91 -0.61 -1.32
Revenue Per Share
 1.94 2.01 1.35 0.83 0.82
Net Income Per Share
 1.14 1.09 0.47 0.80 1.06
Tax Burden
 1.67 1.59 3.91 1.61 2.32
Interest Burden
 0.91 1.04 0.38 1.23 1.04
Research & Development to Revenue
 0.00 <0.01 0.00 <0.01 <0.01
SG&A to Revenue
 0.28 0.32 0.37 0.22 0.19
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.06 0.02
Income Quality
 0.93 1.11 1.69 0.78 0.40
Currency in USD